Its invasion and metastasis process involves the activation of multiple pro-migratory pathways by tumor-intrinsic gene mutations (such as TP53 and CTNNB1), as well as immunosuppression and angiogenesis induced by TME remodeling [38, 39]. The gene discussed is TP53; the disease is neoplasm.